Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy. (January 2013)
- Record Type:
- Journal Article
- Title:
- Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy. (January 2013)
- Main Title:
- Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
- Authors:
- Demir, Mehmet
Oba, Ersin
Can, Efe
Kara, Orhan
Cinar, Sonmez - Abstract:
- We evaluated the effect of intravitreal bevacizumab (IVB) injection before pars plana vitrectomy (PPV) on intravitreal hemorrhage (VH) during and after vitrectomy for postoperative the first day and the first month in pseudophakic patients with proliferative diabetic retinopathy (PDR). This retrospective study was performed on 44 eyes of 44 patients who underwent vitrectomy for PDR. Patients were divided into PPV (n = 22 eyes) and PPV + IVB (n = 22 eyes) groups. Injection of bevacizumab (1.25 mg/0.05 mL) was performed 3 days before vitrectomy. Outcomes of visual acuity as well as intraoperative and postoperative VH were compared between the two groups. One month after surgery, visual acuity improved in PPV and PPV + IVB groups ( P = 0.005, P = 0.006), respectively. There was no difference between the two groups in best corrected visual acuity at baseline and after vitrectomy ( P = 0.71). Intraoperative bleeding into the vitreous was recorded in 14 (63.6%) cases in the PPV group and in 7 (31.8%) cases in the PPV + IVB group. The first month, intravitreal hemorrhage was recorded in six patients in the PPV group and in two patients in the PPV + IVB group ( P = 0.03). The mean pre-postoperative central macular thickness was similar in both groups. Intravitreal injection of IVB before vitrectomy decreased the rate of VH at the time of surgery and at the first postoperative month in patients with PDR.
- Is Part Of:
- Ophthalmology and eye diseases. Volume 5(2013)
- Journal:
- Ophthalmology and eye diseases
- Issue:
- Volume 5(2013)
- Issue Display:
- Volume 5, Issue 2013 (2013)
- Year:
- 2013
- Volume:
- 5
- Issue:
- 2013
- Issue Sort Value:
- 2013-0005-2013-0000
- Page Start:
- Page End:
- Publication Date:
- 2013-01
- Subjects:
- intravitreal bevacizumab -- intravitreal hemorrhage -- proliferative diabetic retinopathy -- vitrectomy
Ophthalmology -- Periodicals
Eye -- Diseases -- Periodicals
Eye Diseases
Ophthalmology
Vision Disorders
Eye -- Diseases
Ophthalmology
Electronic journals
Periodicals
Fulltext
Internet Resources
Periodicals
Periodicals
617.7005 - Journal URLs:
- http://bibpurl.oclc.org/web/44706 ↗
http://www.la-press.com/ophthalmology-and-eye-diseases-journal-j146 ↗
http://journals.sagepub.com/home/oed ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.4137/OED.S12352 ↗
- Languages:
- English
- ISSNs:
- 1179-1721
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25402.xml